期刊文献+

Cys C、SCr、Hb在肾功能改变中的应用 被引量:4

Changes of Blood Cys C,Creatinine and Hemoglobin Levels in Patients with Different Degrees of Renal Function Impairment
暂未订购
导出
摘要 目的:分析胱抑素C(Cys-C)、血肌酐(SCr)、血红蛋白(Hb)在肾功能变化过程的改变情况。方法:回顾性分析201例行肾动态显像患者,记录同时期患者Cys-C、SCr、Hb的水平,并将两者与肾动态显像计算所得GFR_总做相关分析。同时以GFR_总为肾功能改变的分级标准,将201例患者分成5组,观察Cys-C、SCr、Hb水平在肾功能各个阶段的变化情况。结果:在肾功能改变的不同阶段,Cys-C、SCr之间的差别具有显著性(P<0.05);Hb仅在肾功能轻度、中度受损两组间差别不具有显著性(P>0.05)。Cys-C、SCr分别与GFR_总存在明显相关,前者相关程度更高。Hb与GFR_总相关较弱。当60min/ml≤GFR总<80min/ml时,Cys-C较SCr更为敏感,两者之间的差别具有显著性x^2=17.168,P<0.01。Hb降低比例随着肾功能损伤加重而升高,且贫血程度加重。结论:Cys-C较SCr能够更好地反映肾功能的改变,特别在肾功能受损早期更为敏感。随着肾功能损伤的进展,患者贫血程度加重。 Objective To study the changes of blood cystatin C ( Cys C), creatinine and hemogloblin levels in patients with different levels of GFR. Methods GFR levels were examined with renal dynamic imaging ( with 99mTc-DTPA) in 201 patients with various kinds of chronic renal diseases. Blood Cys C, creatinine and hemoglobin levels were determined with biochemistry in these patients. The patients were divided into 5 groups according to their GFR levels: Group A, GFR~〉80min/ml (renal function normal, n = 21 ), Group B, 60ml/min ~〈 GFR 〈 80ml/min ( mild impairment, ,t = 39 ), Group C, 30ml/min 〈 GFR 〈 60ml/min ( moderate im- pairment, n = 50), Group D 15ml/min ≤ GFR 〈 30ml/min ( advanced impairment, n = 37 ) and Group E GFR 〈 15ml/min ( end stage, n = 54). Results The blood levels of of Cys C and creatinine among different groups of patients were all significantly different ( P 〉 0.05 ). Anemia with significant decrease of hemoglobin levels developed in Group D and Group E patiems. Blood levels of both Cys C and ereatinine were significandy negatively correlated with GFR levels. However, in patients with mild renal function impair- ment, Cys C was a more sensitive indicator. In dais study, among the 39 Group B patients, Cys C levels were increased in 32 cases (82.1%), but ereatinine levels were increased in 14 cases (35. 9%) only: the difference was significantly (X2 = 17. 168, P 〈 0.01 ). Conclusion Changes of blood Cys C levels could reflect renal function impairment better than changes of blood ereatinine level did, especially at the initial stage. Anemia developed later in the course of chronic renal failure.
出处 《放射免疫学杂志》 CAS 2011年第1期6-8,共3页 Journal of Radioimmanology
关键词 肾动态显像 肾小球滤过率 胱抑素C 血肌酐 血红蛋白 renal dynamic imaging, GFR, Cystatin C, serum creatinine, hemoglobin
  • 相关文献

参考文献9

二级参考文献38

  • 1李海霞,吴红花,徐国宾,郭晓蕙,夏铁安.血清半胱氨酸蛋白酶抑制剂C与肌酐在评价糖尿病患者肾小球滤过功能中的比较研究[J].中华检验医学杂志,2005,28(6):602-605. 被引量:107
  • 2陈灏珠.内科学第4版[M].北京:人民卫生出版社,1997.743-753.
  • 3[1]Barrett AJ, Davies ME, Grubb A. The place of human gamma-trace (Cystatin C) amongst the cysteine proteinase inhibitors[J ]. Biochem Biophys Res Commun, 1984, 120:631.
  • 4[2]Sirmonsen O, Grubb A, Thysell H. The Blood serum concentration of cystatin C as a measure of glomerular filtration rate[J ]. Scand J Clin Lab Invest, 1985, 45:97.
  • 5[3]Tian S, Kusano E, Tabei K, et al. Cystatin C measurement and its practical use in patients with various renal diseases[J ]. Clin Nephrol,1997, 48:104.
  • 6[4]David JN, Hansa T, Robert GD, et al. Serum Cystatin C measured by automated immunoassay: a more sensitive marker of changes in GFR than serum creatinine[J]. Kidney International, 1995, 47:312.
  • 7[5]Finney H, Newman DJ, Gruber W, et al. Initial evaluation of cystatin C measurement by particle enhanced immunonephelometry on the Behring nephelometer systems BNA,BNII[J ]. Clin Chem, 1997, 43:1016.
  • 8[6]Fanos V, Mussap M, Plebani M, et al. Cystatin C in paediatric nephrology. Present situation and prospects [J ]. Minerva-Pediatr,1999, 51:167.
  • 9[7]Jung K, Jung M. Cystatin C: a promising marker of glomerular filtration rate to replace creatinine[J]. Nephron, 1995, 70:370.
  • 10[8]Ylinen EA, Ala Houhala M, Harmoinen AP, et al. Cystatin C as a marker for glomemlar filtration rate in pediatric patients[J ]. Pediatr Nephrol, 1999, 13:506.

共引文献203

同被引文献30

  • 1关美萍,李晨钟,薛耀明,沈洁,高方,罗祥容.2型糖尿病合并高血压病患者尿微量白蛋白患病率研究[J].第一军医大学学报,2005,25(2):234-235. 被引量:2
  • 2霍勇,洪涛.经皮冠状动脉介入技术是当前治疗急性冠状动脉综合征的重要手段[J].中华心血管病杂志,2006,34(6):481-482. 被引量:11
  • 3张继武,张策,何军明,向松涛,朱丽娟,邹泓.梗阻性肾病治疗前后的分侧肾小球滤过率测定的相关性分析[J].中国辐射卫生,2006,15(4):496-497. 被引量:7
  • 4吴阶平.吴阶平泌尿外科学[M].济南:山东科学技术出版社,2004.589-591.
  • 5Anderson JL,Adams CD,Antman EM,etal. ACA2/AHA 2007 guide- lines for the management of patients with unstable angina/non-ST-el- evation myocardial infarction..A report oF the American college o: car- diology/American heart association task force on practice guidelines [J]. J Am Coll Cardiol,2007,50(1) ..e155-e157.
  • 6Persson PB, Hansell P,Liss P. Pathophysiology o{ contrast medium- induced nephropathy[J]. Kidney Int, 2005,68 (1) .. 14-22.
  • 7Kelly AM, Dwamena B, Cronin P, et al. Meta-analysis: Effectiveness of drugs for preventing contrast-induced nephropathy [J]. Ann Intern Med,2008,148(4) : 284-294.
  • 8Giuseppe P, Annunziata N, Massimo C, et al. Usefulness of statin pre- treatment to prevent contrast-induced nephropathy and to improvelong-term outcome in patients undergoing percutaneous coronary in- tervention [J]. Am J Cardiology,2008,101(3) : 279-285.
  • 9Attallah N,Yassine L,Musial J,et al. The potential role of statins in contras nephropathy[J]. Clin Nephrol, 2004,62(4) : 273-278.
  • 10Patti G, Nusca A, Chello M, et al. Usefulness of statin pretreatment to prevent contrast-induced nephropathy and to improve long-term out- come in patients undergoing percutaneous coronary intervention [J]. Am J Cardiol,2008,101(3) :279-285.

引证文献4

二级引证文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部